Country-site completeness matrix with overdue and needs-QC detection. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.
| Country | Completeness | Overdue Artifacts | Needs QC |
|---|---|---|---|
| US | 88% | 319 | 692 |
| CA | 87% | 337 | 677 |
| GB | 89% | 290 | 678 |
| DE | 88% | 313 | 690 |
| FR | 87% | 337 | 648 |
| ES | 88% | 309 | 613 |
| IT | 88% | 313 | 672 |
| NL | 89% | 299 | 657 |
| BE | 88% | 315 | 685 |
| SE | 88% | 310 | 651 |
Study firewalling chips highlight boundary, country constraints, and vendor partition rules.
Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.
Every state change writes immutable audit evidence with actor, timestamp, and object reference.
Filter to portfolio/program/study context.
Open linked tasks, risks, and document evidence.
Escalate blocked items through governed workflow.